This Cochrane Clinical Answer evaluates non-checkpoint-based immunotherapy in people with stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.
A subscription to THE COCHRANE LIBRARY is required.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.